Zhang Zhoupeng, Tang Wei
Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Sharp & Dohme Corp., West Point, PA 19486, USA.
Shanghai ChemPartners, Shanghai 201203, China.
Acta Pharm Sin B. 2018 Sep;8(5):721-732. doi: 10.1016/j.apsb.2018.04.003. Epub 2018 Apr 12.
Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered. This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of drug candidates; these include, but are not limited to, collaboration with medicinal chemists on structure-activity relationships (SAR) to overcome high clearance, using deuterium replacement to further optimize a lead, prodrug approaches to circumvent formulation and delivery difficulties, and addressing issues such as species differences in metabolism, drug-drug interactions (DDI) and formation of reactive metabolites.
药物代谢作为一门学科,在药物研发中发挥着重要作用,应仔细考虑药物代谢对药代动力学(PK)、药效学(PD)和安全性的影响。本交流概述了药物代谢领域中用于改善候选药物的PK/PD和安全性概况的常见策略;这些策略包括但不限于与药物化学家就构效关系(SAR)进行合作以克服高清除率、使用氘取代进一步优化先导化合物、采用前药方法规避制剂和给药困难,以及解决诸如代谢的种属差异、药物相互作用(DDI)和活性代谢物形成等问题。